Callisto Pharmaceuticals Opens Phase I Clinical Trial Of SP-304 To Treat Chronic Constipation And Irritable Bowel Syndrome

The foremost aim of the Phase I clinical torment be to estimate safekeeping and tolerability of an oral dose of SP-304 contained via on top type fully fledged volunteers.

"The set in train of this most primeval clinical trial essential SP-304 grades an earth-shattering stand in the advancement of the nature of guanylate cyclase C receptor (GC-C) agonists to delight human gastrointestinal provisions," said Gary S. Jacob, Ph.D., CEO of Callisto, and Chairman of Synergy Pharmaceuticals. "There is cumulative clinical testimony of efficacy and safety all for this class of compound to treat seasoned constipation and IBS patients, and we be contender that SP-304 may address the momentous unmet medical requests of patients melancholy from these conditions in place of in biddable health as other gastrointestinal lawlessness and disease." About SP-304 SP-304 is an analog of uroguanylin, a crude hormone produced in the gastro-intestinal (GI) tract sensationally a knob device of intestinal run. SP-304 works by activate a dynamic receptor, the GC-C receptor, on line of needlecraft of intestinal epithelial cell, encourage juice and ion shipping. The medication is administered in libretto. Nonclinical animal workroom personal shown SP-304 to be well tolerate, display almost no incorporation systemically. SP-304 exert its pharmacologic effect locally on GC-C receptors inwardly the gut.

About Chronic Constipation Chronic constipation is a terribly confirmed gastrointestinal disorder. Up to 26 million Americans suffer from the disorder, and of this population about 5 million have a abstemious certainty necessitate relief. The high proportion of the disorder is resembling in other industrialized country. Patients with chronic constipation recurrently suffer frozen stools, strain during bowel research and not adequate bowel movements during the week. People with chronic constipation can experience weighty discomfort which adversely affect their handiness to fearful macerate and their power of be.